For example, macrophage migration inhibitory factor (MIF) can inhibit the activation of EGFR, while EGFR can promote the growth of various tumors and has been identified as a key therapeutic target of epithelial ovarian cancer (Sheng and Liu, 2011; Zheng et al., 2015). This evidence concerns the gene EGFR and ovarian carcinoma.